U.S. Stem Cell, Inc. (USRM) financial statements (2021 and earlier)

Company profile

Business Address 1560 SAWGRASS CORPORATE PKWY
SUNRISE, FL 33323
State of Incorp. FL
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments110000
Cash and cash equivalents110000
Receivables000000
Inventory, net of allowances, customer advances and progress billings0000 
Inventory0000  
Other undisclosed current assets00 000
Total current assets:210000
Noncurrent Assets
Property, plant and equipment000000
Deposits noncurrent assets0000  
Other noncurrent assets     0
Other undisclosed noncurrent assets00000 
Total noncurrent assets:000000
TOTAL ASSETS:220000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities222257
Accounts payable111222
Accrued liabilities111124
Employee-related liabilities    0 
Interest and dividends payable    1 
Settlement liabilities00   
Debt1200  
Derivative instruments and hedges, liabilities  001 
Due to related parties000000
Deferred revenue and credits000  
Other undisclosed current liabilities323356
Total current liabilities:66661113
Noncurrent Liabilities
Long-term debt and lease obligation1111  
Long-term debt, excluding current maturities1111  
Capital lease obligations00    
Liabilities, other than long-term debt0000  
Deferred revenue and credits00   
Deferred gain on sale of property0
Due to related parties   0  
Other undisclosed noncurrent liabilities1111  
Total noncurrent liabilities:3222  
Total liabilities:99881113
Stockholders' equity
Stockholders' equity attributable to parent, including:(7)(7)(8)(8)(11)(14)
Preferred stock  00  
Common stock0000  
Treasury stock, value   (0)  
Additional paid in capital123120116115109104
Accumulated deficit(130)(128)(124)(122)(120) 
Other undisclosed stockholders' equity attributable to parent    1(118)
Total stockholders' equity:(7)(7)(8)(8)(11)(14)
Other undisclosed liabilities and equity     0
TOTAL LIABILITIES AND EQUITY:220000

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues763220
Revenue, net63220
Cost of revenue
(Cost of Goods and Services Sold)
(2)(2)(1)(1)(1)(0)
Gross profit:542110
Operating expenses(6)(4)(3)(4)(6)(3)
Other undisclosed operating income    1 
Operating loss:(1)(1)(1)(3)(4)(3)
Nonoperating income (expense)(1)(3)(1)11(0)
Investment income, nonoperating0(2)0000
Other nonoperating income  00 0
Interest and debt expense0(0)031(0)
Income (loss) from continuing operations before equity method investments, income taxes:(2)(4)(2)1(1)(4)
Loss from equity method investments    (0) 
Other undisclosed income (loss) from continuing operations before income taxes(0)0(0)(3)(1)0
Loss from continuing operations before income taxes:(2)(3)(2)(2)(2)(3)
Income tax benefit    0 
Net loss:(2)(3)(2)(2)(2)(3)
Other undisclosed net loss attributable to parent    (0) 
Net loss available to common stockholders, diluted:(2)(3)(2)(2)(2)(3)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(2)(3)(2)(2)(2)(3)
Comprehensive loss, net of tax, attributable to parent:(2)(3)(2)(2)(2)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: